What to know when launching Pfizer’s COVID19 vaccine for children under 12

Children aged five to eleven in the United States can finally benefit from a COVID19 vaccine. On November 2, federal health officials approved the vaccination of these school-aged children. The move follows an Oct. 26 meeting of a U.

Food and Drug Administration advisory group. This group expressed its approval for the vaccine from Pfizer and its German partner BioNTech to be available for school-aged children under 12 years of age. A second advisory group for the US Centers for Disease Control and Prevention met on November 2.

This panel also said that children between the ages of 5 and 11 could receive the vaccine. In making this decision, experts on the FDA panel questioned whether the benefits of the vaccine outweighed its risks.COC panels also discussed benefits and risks.”And we do not want them in the ICU.”He is also chief medical officer of the Duke Human Vaccine Institute.

Once vaccinated, he notes, children can go to school, play sports and “do the normal things that kids want to do.” Vaccinations are essential to prevent COVID19. Here’s what you need to know about this disease and the Pfizer vaccine in children under 12. of school age.